Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 02/11/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
9 | |
| 02/11/21 | DEF 14A | Definitive proxy statements |
|
11 | |
| 02/11/21 | 8-K | Current report filing |
|
5 | |
| 02/11/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 02/10/21 | 8-K | Current report filing |
|
36 | |
| 02/09/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
50 | |
| 02/09/21 | 8-K | Current report filing |
|
26 | |
| 02/08/21 | 8-K | Current report filing |
|
4 | |
| 01/29/21 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
9 | |
| 01/14/21 | 8-K | Current report filing |
|
5 |
